Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Bosentan + Dacarbazine in Stage IV Metastatic Melanoma
NCT01009177Phase 2Completed
- Sponsor
- Actelion Pharmaceuticals Ltd
- Start
- Sep 2005
- Primary completion
- Feb 2008
- Modality
- Nucleic Acid-Directed Small Molecules, Orthosteric Ligands
- Countries
- 1
01
Overview
A Phase 2 trial of bosentan in melanoma, sponsored by Actelion Pharmaceuticals Ltd. Started Sep 2005; status: completed.
02
Drugs
bosentan
03
Conditions
melanoma
Beyond the preview
Go deeper on NCT01009177.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01009177.